AMREP CORP (AXR) Fundamental Analysis & Valuation

NYSE:AXR • US0321591051

Current stock price

28.13 USD
+0.38 (+1.37%)
At close:
28.13 USD
0 (0%)
After Hours:

This AXR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. AXR Profitability Analysis

1.1 Basic Checks

  • AXR had positive earnings in the past year.
  • In the past year AXR had a positive cash flow from operations.
  • Each year in the past 5 years AXR has been profitable.
  • In the past 5 years AXR always reported a positive cash flow from operatings.
AXR Yearly Net Income VS EBIT VS OCF VS FCFAXR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

1.2 Ratios

  • AXR has a Return On Assets of 8.98%. This is amongst the best in the industry. AXR outperforms 96.77% of its industry peers.
  • AXR has a Return On Equity of 9.28%. This is amongst the best in the industry. AXR outperforms 83.87% of its industry peers.
  • AXR has a Return On Invested Capital of 8.52%. This is amongst the best in the industry. AXR outperforms 95.16% of its industry peers.
  • AXR had an Average Return On Invested Capital over the past 3 years of 7.98%. This is above the industry average of 5.74%.
  • The 3 year average ROIC (7.98%) for AXR is below the current ROIC(8.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.98%
ROE 9.28%
ROIC 8.52%
ROA(3y)11.25%
ROA(5y)11.62%
ROE(3y)11.7%
ROE(5y)12.51%
ROIC(3y)7.98%
ROIC(5y)10.76%
AXR Yearly ROA, ROE, ROICAXR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • AXR has a Profit Margin of 24.40%. This is amongst the best in the industry. AXR outperforms 88.71% of its industry peers.
  • AXR's Profit Margin has declined in the last couple of years.
  • The Operating Margin of AXR (26.06%) is better than 91.94% of its industry peers.
  • In the last couple of years the Operating Margin of AXR has declined.
  • With a decent Gross Margin value of 42.44%, AXR is doing good in the industry, outperforming 69.35% of the companies in the same industry.
  • In the last couple of years the Gross Margin of AXR has grown nicely.
Industry RankSector Rank
OM 26.06%
PM (TTM) 24.4%
GM 42.44%
OM growth 3Y-12.34%
OM growth 5YN/A
PM growth 3Y-1.77%
PM growth 5YN/A
GM growth 3Y-4.88%
GM growth 5Y19.57%
AXR Yearly Profit, Operating, Gross MarginsAXR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. AXR Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AXR is destroying value.
  • AXR has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, AXR has less shares outstanding
  • The debt/assets ratio for AXR has been reduced compared to a year ago.
AXR Yearly Shares OutstandingAXR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
AXR Yearly Total Debt VS Total AssetsAXR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • AXR has an Altman-Z score of 22.01. This indicates that AXR is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of AXR (22.01) is better than 96.77% of its industry peers.
  • AXR has a debt to FCF ratio of 0.00. This is a very positive value and a sign of high solvency as it would only need 0.00 years to pay back of all of its debts.
  • AXR's Debt to FCF ratio of 0.00 is amongst the best of the industry. AXR outperforms 91.94% of its industry peers.
  • AXR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.00, AXR belongs to the top of the industry, outperforming 90.32% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 22.01
ROIC/WACC0.95
WACC8.99%
AXR Yearly LT Debt VS Equity VS FCFAXR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.3 Liquidity

  • A Current Ratio of 25.70 indicates that AXR has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 25.70, AXR belongs to the best of the industry, outperforming 98.39% of the companies in the same industry.
  • AXR has a Quick Ratio of 11.00. This indicates that AXR is financially healthy and has no problem in meeting its short term obligations.
  • AXR's Quick ratio of 11.00 is amongst the best of the industry. AXR outperforms 96.77% of its industry peers.
Industry RankSector Rank
Current Ratio 25.7
Quick Ratio 11
AXR Yearly Current Assets VS Current LiabilitesAXR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. AXR Growth Analysis

3.1 Past

  • The earnings per share for AXR have decreased by -0.33% in the last year.
  • Measured over the past 5 years, AXR shows a small growth in Earnings Per Share. The EPS has been growing by 2.33% on average per year.
  • The Revenue has decreased by -8.70% in the past year.
  • AXR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.46% yearly.
EPS 1Y (TTM)-0.33%
EPS 3Y2.33%
EPS 5YN/A
EPS Q2Q%338.11%
Revenue 1Y (TTM)-8.7%
Revenue growth 3Y-5.51%
Revenue growth 5Y21.46%
Sales Q2Q%93.79%

3.2 Future

  • AXR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.71% yearly.
  • Based on estimates for the next years, AXR will show a quite strong growth in Revenue. The Revenue will grow by 11.91% on average per year.
EPS Next Y-4.9%
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%
EPS Next 5Y2.71%
Revenue Next Year12.43%
Revenue Next 2Y8.39%
Revenue Next 3Y8.21%
Revenue Next 5Y11.91%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
AXR Yearly Revenue VS EstimatesAXR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M
AXR Yearly EPS VS EstimatesAXR Yearly EPS VS EstimatesYearly EPS VS Estimates 2026 2027 2028 2029 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

7

4. AXR Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 11.67 indicates a reasonable valuation of AXR.
  • Based on the Price/Earnings ratio, AXR is valued cheaper than 83.87% of the companies in the same industry.
  • AXR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.35.
  • AXR is valuated correctly with a Price/Forward Earnings ratio of 13.33.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AXR indicates a rather cheap valuation: AXR is cheaper than 93.55% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of AXR to the average of the S&P500 Index (22.61), we can say AXR is valued slightly cheaper.
Industry RankSector Rank
PE 11.67
Fwd PE 13.33
AXR Price Earnings VS Forward Price EarningsAXR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • AXR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AXR is cheaper than 95.16% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, AXR is valued cheaply inside the industry as 85.48% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.39
EV/EBITDA 6.9
AXR Per share dataAXR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • AXR has an outstanding profitability rating, which may justify a higher PE ratio.
  • AXR's earnings are expected to decrease with -2.55% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AXR Dividend Analysis

5.1 Amount

  • No dividends for AXR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AXR Fundamentals: All Metrics, Ratios and Statistics

AMREP CORP

NYSE:AXR (3/31/2026, 4:15:00 PM)

After market: 28.13 0 (0%)

28.13

+0.38 (+1.37%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)03-12
Earnings (Next)07-23
Inst Owners44.69%
Inst Owner Change-0.97%
Ins Owners45.64%
Ins Owner Change2.43%
Market Cap149.37M
Revenue(TTM)53.00M
Net Income(TTM)12.93M
Analysts80
Price Target23.46 (-16.6%)
Short Float %0.82%
Short Ratio3.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-24.87%
Min EPS beat(2)-50.49%
Max EPS beat(2)0.75%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-17.5%
Min Revenue beat(2)-37.84%
Max Revenue beat(2)2.84%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-23.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-12.55%
Valuation
Industry RankSector Rank
PE 11.67
Fwd PE 13.33
P/S 2.82
P/FCF 11.39
P/OCF 10.95
P/B 1.07
P/tB 1.07
EV/EBITDA 6.9
EPS(TTM)2.41
EY8.57%
EPS(NY)2.11
Fwd EY7.5%
FCF(TTM)2.47
FCFY8.78%
OCF(TTM)2.57
OCFY9.14%
SpS9.98
BVpS26.25
TBVpS26.25
PEG (NY)N/A
PEG (5Y)N/A
Graham Number37.73
Profitability
Industry RankSector Rank
ROA 8.98%
ROE 9.28%
ROCE 9.91%
ROIC 8.52%
ROICexc 13.29%
ROICexgc 13.34%
OM 26.06%
PM (TTM) 24.4%
GM 42.44%
FCFM 24.74%
ROA(3y)11.25%
ROA(5y)11.62%
ROE(3y)11.7%
ROE(5y)12.51%
ROIC(3y)7.98%
ROIC(5y)10.76%
ROICexc(3y)10.52%
ROICexc(5y)13.87%
ROICexgc(3y)10.56%
ROICexgc(5y)13.9%
ROCE(3y)9.27%
ROCE(5y)12.5%
ROICexgc growth 3Y-24.11%
ROICexgc growth 5YN/A
ROICexc growth 3Y-24.15%
ROICexc growth 5YN/A
OM growth 3Y-12.34%
OM growth 5YN/A
PM growth 3Y-1.77%
PM growth 5YN/A
GM growth 3Y-4.88%
GM growth 5Y19.57%
F-Score5
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 179.26%
Cap/Sales 1.01%
Interest Coverage 250
Cash Conversion 96.71%
Profit Quality 101.38%
Current Ratio 25.7
Quick Ratio 11
Altman-Z 22.01
F-Score5
WACC8.99%
ROIC/WACC0.95
Cap/Depr(3y)283.02%
Cap/Depr(5y)282.35%
Cap/Sales(3y)0.78%
Cap/Sales(5y)0.91%
Profit Quality(3y)86%
Profit Quality(5y)103.5%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.33%
EPS 3Y2.33%
EPS 5YN/A
EPS Q2Q%338.11%
EPS Next Y-4.9%
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%
EPS Next 5Y2.71%
Revenue 1Y (TTM)-8.7%
Revenue growth 3Y-5.51%
Revenue growth 5Y21.46%
Sales Q2Q%93.79%
Revenue Next Year12.43%
Revenue Next 2Y8.39%
Revenue Next 3Y8.21%
Revenue Next 5Y11.91%
EBIT growth 1Y4.28%
EBIT growth 3Y-17.16%
EBIT growth 5YN/A
EBIT Next Year19.88%
EBIT Next 3Y1.05%
EBIT Next 5Y6.19%
FCF growth 1Y20.66%
FCF growth 3Y-12.03%
FCF growth 5Y66.27%
OCF growth 1Y22.02%
OCF growth 3Y-12.86%
OCF growth 5Y67.79%

AMREP CORP / AXR Fundamental Analysis FAQ

What is the fundamental rating for AXR stock?

ChartMill assigns a fundamental rating of 7 / 10 to AXR.


What is the valuation status for AXR stock?

ChartMill assigns a valuation rating of 7 / 10 to AMREP CORP (AXR). This can be considered as Undervalued.


What is the profitability of AXR stock?

AMREP CORP (AXR) has a profitability rating of 8 / 10.


What are the PE and PB ratios of AMREP CORP (AXR) stock?

The Price/Earnings (PE) ratio for AMREP CORP (AXR) is 11.67 and the Price/Book (PB) ratio is 1.07.


How financially healthy is AMREP CORP?

The financial health rating of AMREP CORP (AXR) is 9 / 10.